Long time lurker but felt the need to surface in order to comment here:
Data exists that autopsies are not particularly detrimental to defense of malpractice suits at therefore should not be avoided to "protect other clinicial services":
Bove KE, Iery C; Autopsy Committee, College of American Pathologists. The role of the autopsy in medical malpractice cases, I: a review of 99 appeals court decisions. Arch Pathol Lab Med. 2002 Sep;126(9):1023-31. Review. PubMed PMID: 12204050.
Data exists that the rate at which autopsies detect missed diagnoses/misunderstood findings has not changed over several decades despite the increase in imaging modalities and studies:
- Sonderegger-Iseli K, Burger S, Muntwyler J, Salomon F. Diagnostic errors in three medical eras: a necropsy study. Lancet. 2000; 355(9220):2027-31.
- Shojania KG, Burton EC, McDonald KM, Goldman L. Changes in rates of autopsy-detected diagnostic errors over time: a systematic review. JAMA. 2003; 289(21):2849-56.
- Pastores SM, Dulu A, Voigt L, Raoof N, Alicea M, Halpern NA. Premortem clinical diagnoses and postmortem autopsy findings: discrepancies in critically ill cancer patients. Crit Care. 2007; 11(2):R48
- Wittschieber D, Klauschen F, Kimmritz AC, von Winterfeld M, Kamphues C, Scholman HJ, Erbersdobler A, Pfeiffer H, Denkert C, Dietel M, Weichert W, Budczies J, Stenzinger A. Who is at risk for diagnostic discrepancies? Comparison of pre- and postmortal diagnoses in 1800 patients of 3 medical decades in East and West Berlin. PLoS One. 2012; 7(5):e37460.
Autopsies aren't billable but are covered by various payments to the institutions (hospitals) because they play a role in QA and QI activities. Our failure to educate other physicians about the importance of autopsy in understanding disease, understanding course for individual patients and understanding poor outcomes lies at the heart of much of the discussion which has already occurred here. With the increasing frequency of patients to have been involved in clincial trials (oncologic, cardiovascular, etc), the need to assess the distribution and character of pathologic processes post-treatment has taken on an increasing role. This is not a role for which forensic pathologists are trained. In fact, this type of activity should be a critical position for the pathologist in the health care delivery system, rather than simply anonymously rendering diagnoses as a simple interface between a glass slide and an electronic document. When seen as a critical player in understanding health outcomes, the pathologist becomes an increasing important member of the community -- this will be the key to gaining an appropriate share of resources when reduced reimbursements are being distributed within Accountable Care Organizations.